Trial intelligence / Profile preview

D-cycloserine + CBT for PTSD in Youth

NCT01157416Phase 2Completed

Sponsor
Tulane University
Start
Jun 2010
Primary completion
Jun 2012
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing D-cycloserine plus CBT with Placebo plus CBT (2 arms). Primary endpoint: Child PTSD Symptom Scale at 28 weeks. Started Jun 2010; status: completed.

02

Drugs

d-cycloserine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01157416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01157416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call